Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL) Clinical Trials in Chengdu, Chengdu

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma